MuRF-1 and MAFbx regulate pathological and physiological skeletal muscle atrophy.
MuRF-1 and MAFbx are regulated by the FOXO, MAPK and NF-kB signaling pathways.
Clinical evidence for MuRF-1 and MAFbx role in common human pathologies is lacking.
Lifestyle factors (nutrition, exercise, smoking, etc.) affect MuRF-1 and MAFbx regulation.
Inhibitors of MuRF-1 and MAFbx expression prevent muscle loss in experimental models.